Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) – Jefferies Group upped their FY2017 earnings per share (EPS) estimates for shares of Sabra Healthcare REIT in a research report issued on Monday. Jefferies Group analyst O. Okusanya now anticipates that the real estate investment trust will post earnings per share of $2.38 for the year, up from their previous forecast of $2.36. Jefferies Group has a “Buy” rating and a $24.00 price target on the stock. Jefferies Group also issued estimates for Sabra Healthcare REIT’s FY2018 earnings at $2.32 EPS and FY2019 earnings at $2.31 EPS.
ILLEGAL ACTIVITY WARNING: “FY2017 EPS Estimates for Sabra Healthcare REIT, Inc. Boosted by Analyst (SBRA)” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.thestockobserver.com/2017/11/14/fy2017-eps-estimates-for-sabra-healthcare-reit-inc-boosted-by-analyst-sbra.html.
Several other brokerages have also weighed in on SBRA. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. TheStreet lowered Sabra Healthcare REIT from a “b-” rating to a “c” rating in a report on Friday, November 3rd. Capital One Financial Corporation initiated coverage on Sabra Healthcare REIT in a report on Monday, September 25th. They issued an “equal weight” rating and a $24.00 price objective for the company. Zacks Investment Research lowered Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $24.40.
Sabra Healthcare REIT (SBRA) opened at $18.95 on Tuesday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.89. Sabra Healthcare REIT has a one year low of $18.89 and a one year high of $29.10. The company has a market capitalization of $3,468.40, a PE ratio of 8.54, a P/E/G ratio of 2.52 and a beta of 0.94.
Large investors have recently bought and sold shares of the company. California Public Employees Retirement System grew its holdings in shares of Sabra Healthcare REIT by 8.1% during the second quarter. California Public Employees Retirement System now owns 121,200 shares of the real estate investment trust’s stock valued at $2,921,000 after purchasing an additional 9,100 shares during the last quarter. Piedmont Investment Advisors LLC bought a new position in shares of Sabra Healthcare REIT during the second quarter valued at approximately $340,000. OMERS ADMINISTRATION Corp bought a new position in shares of Sabra Healthcare REIT during the second quarter valued at approximately $2,453,000. Voya Investment Management LLC grew its holdings in shares of Sabra Healthcare REIT by 354.5% during the second quarter. Voya Investment Management LLC now owns 119,050 shares of the real estate investment trust’s stock valued at $2,869,000 after purchasing an additional 92,854 shares during the last quarter. Finally, Marshall Wace North America L.P. bought a new position in shares of Sabra Healthcare REIT during the second quarter valued at approximately $1,327,000. 99.26% of the stock is owned by institutional investors.
The business also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Tuesday, November 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 153.19%.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.